Focus: Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in Norcross, Georgia, specializing in small molecules and custom pharma services across five major therapeutic areas including oncology and neurology.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Dr. Reddy's Laboratories to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dr. Reddy's Laboratories
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Dr. Reddy's Laboratories's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Proteasome inhibitor carrying 15% of company revenue with 9+ year patent runway; core foundation of current profitability.
Post-exclusivity antiarrhythmic generating modest revenue; faces generic competition and limited growth prospects.
Immunomodulator for inflammation; post-exclusivity with stable but erosive market share.
Immunosuppressant for transplant; established utility but mature market with significant generic competition.
Topical antimicrobial facing imminent exclusivity cliff; niche specialty indication but declining revenue.
209 discontinued, 302 duplicate formulations not shown
+5 more products with revenue data
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Source: state DOL filings, aggregated via Big Local News
No recent public compliance or product quality issues detected, but absence of hiring signals suggests underlying restructuring or cost containment.
+235 more products